Rosetrees is a private charity which uses entrepreneurial skills to find and fund the best medical research.

We support outstanding thinkers with new ideas to improve treatments and one day find cures.

Blood vessel network in colorectal cancer imaged using OPT.

Blood vessel network in human colorectal cancer, imaged using OPT.

www.tomrobertsphoto.com                     Rosetrees symposium at Institute of Child Health, UCL, 2017.

David Gutteridge

Dr. Simon-Walker-Samuel, UCL

We have a simple application and reporting system and a personal approach meeting researchers once a year. Formed in 1987, Rosetrees gives long term support to the best researchers to develop their ideas and achieve medical breakthroughs.

 

For more information about Rosetrees, its expertise or co-donors, please click here.

 Contacting Rosetrees

In accordance with government guidelines regarding office working in tier 4, all of our staff will be remote working from home until further notice. Please contact individual team members by e-mail or if you have a general enquiry, please e-mail info@rosetreestrust.co.uk

Rosetrees funding for COVID-19 research

Since the outbreak of the covid pandemic in February 2020, Rosetrees launched a rapid-response call to pump-priming vital research aimed at developing rapid diagnostics, new treatments and a better understanding of long covid. We received over 50 applications and are funding 24 projects at a total cost of almost £1 million.

This call has now closed. If you have have a covid related project, this can be submitted through our project grant scheme opening on January 6th 2021.

During the height of the pandemic, some of our leading scientists were involved in developing and delivering key equipment to the NHS, such as Professor Rebecca Shipley at UCL who in partnership with Mercedes developed and delivered a breathing aid that can help keep coronavirus patients out of intensive care. If you would like to donate to Rosetrees Trust covid funding, please click here.

Furthermore, as we have been so concerned about the impact of the covid situation generally, not only have we made emergency funding available for research projects but exceptionally, we have also made grants to support the homeless and also to help people who are unable to buy food. These are exceptional times and as a result the Trustees have authorised us to make donations to Crisis, Shelter, and the Trussell Trust (foodbanks). We hope our partners and supporters also consider supporting these essential charities.

 

Rosetrees researchers affected by COVID-19

We hope that our community of researchers and partners are keeping well at this difficult time.

We encourage all our researchers to get in touch and share their plans with us. We want to continue supporting our projects where we can and we would ask you to respond to project update requests with as much information as possible so that we can make decisions without delay.

Keep well and we look forward to the entire research community returning to work and identifying answers to important questions.

About Us

UCL

Latest News

Dr. Melina Schuh, MPI, Göttingen

Apply for Funding

Dr. Melina Schuh, MPI, Göttingen

Study (published today in The Lancet) of 51 healthcare workers showed that those who have had COVID-19 have an enhanced antibody response after a single dose of Pfizer/BioNTech vaccine compared to uninfected individuals who had either one or two vaccination doses. @AineMcKnight

Study (published today in The Lancet) of 51 healthcare workers showed that those who have had COVID-19 have an enhanced antibody response after a single dose of Pfizer/BioNTech vaccine compared to uninfected individuals who had either one or two vaccination doses. @AineMcKnight

A collaborative study (published today in The Lancet) of 51 healthcare workers showed that those who have had COVID-19 have an enhanced antibody response after a single dose of Pfizer/BioNTech vaccine compared to uninfected individuals who had either one or two vaccination doses.

A collaborative study (published today in The Lancet) of 51 healthcare workers showed that those who have had COVID-19 have an enhanced antibody response after a single dose of Pfizer/BioNTech vaccine compared to uninfected individuals who had either one or two vaccination doses.

Cambridge scientists (part funded by Rosetrees) have successfully grown bile duct organoids for use in repairing patient livers or damaged donor organs used in transplantation. It's the first time the technique has been used on human organs. Sampaziotis, F et al. Science; 18/2/21

Load More...